Search results

  1. forestglip

    Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients 2023, Glass, Hanson et al

    I think the claim isn't so much meant to be that there is a total lack of change, but that there is a lack of change associated with exercise. For instance, we could imagine some variable that has a huge amount of variability day to day in most people, like step count. If we do an intervention...
  2. forestglip

    Developing a blood cell-based diagnostic test for ME/CFS using peripheral blood mononuclear cells, 2023, Xu, Morten et al

    This quote from Dr. Xu in the webinar seems to say that they did not allow cells to be split up:
  3. forestglip

    Neuroinflammation: an unfortunate term to describe schizophrenia, 2026, Llorca-Bofí et al

    The abstract seems relevant to posts from users like @Jonathan Edwards about the terms "inflammation" and "neuroinflammation" often not being used appropriately in papers.
  4. forestglip

    Neuroinflammation: an unfortunate term to describe schizophrenia, 2026, Llorca-Bofí et al

    Neuroinflammation: an unfortunate term to describe schizophrenia Abstract Schizophrenia, a chronic psychiatric disorder, has prompted extensive research into its immunological aspects. Studies in genetics, epidemiology, and treatment have revealed immune changes associated with schizophrenia...
  5. forestglip

    Developing a blood cell-based diagnostic test for ME/CFS using peripheral blood mononuclear cells, 2023, Xu, Morten et al

    Are we talking about a different paper? Isn't this the thread? My very limited understanding of cross-validation was that the setup was this: Create some number of folds from the dataset. Train with some folds, test with the last fold. You have test results for one fold. Repeat five times...
  6. forestglip

    Developing a blood cell-based diagnostic test for ME/CFS using peripheral blood mononuclear cells, 2023, Xu, Morten et al

    She talks about cross-validation in the video and I see this in the paper: Though my knowledge of ML training/testing practices is pretty limited.
  7. forestglip

    Developing a blood cell-based diagnostic test for ME/CFS using peripheral blood mononuclear cells, 2023, Xu, Morten et al

    I was thinking it was maybe that, but it's the same number of predictions in both result figures. It seems like it'd be weird to still count multiple cells from one prediction as different predictions when describing the results.
  8. forestglip

    Outcomes of ME/CFS Following Infectious Mononucleosis: Seven-year Follow-up of a Prospective Study, 2026, Jason et al

    Outcomes of ME/CFS Following Infectious Mononucleosis: Seven-year Follow-up of a Prospective Study Leonard A. Jason, Jacob Furst, Rebecca Worth, Ben Katz [Line breaks added] Background Many individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) report experiencing an...
  9. forestglip

    Developing a blood cell-based diagnostic test for ME/CFS using peripheral blood mononuclear cells, 2023, Xu, Morten et al

    One of the authors, Jiabao Xu, presented about this and other Raman spectroscopy-related research at the recent PRIME project webinar (from 38:54 to 1:07:32, link to thread). She says they went on to try a similar method in lupus. They split up lupus patients by organs affected...
  10. forestglip

    University of Edinburgh - ME/CFS research fundraising

    Some posts about an upcoming blood-based biomarker study from University of Edinburgh have been moved to: News about research from University of Edinburgh
  11. forestglip

    "Severe ME/CFS and long Covid in secondary care: guide to management during patient hospital stays" (ANZMES)

    I'm not sure how this relates or when it was made, but here's another guide from ANZMES, also labeled with ME Respite logo: Hospital Care Plan for Severe-Very Severe ME/CFS and long COVID (and associated conditions, e.g.: dysautonomia) (PDF) I saw it shared on Bluesky by Tom Kindlon.
  12. forestglip

    Preprint Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric [LC] Development up to [12 Mo post-C19] Symptom Onset, 2026, Samaan et al

    Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months Post-COVID-19 Symptom Onset [Line breaks added] Abstract Infection with SARS-CoV-2 can lead to long COVID, a chronic multisystemic condition estimated to affect approximately...
  13. forestglip

    Trial By Error: 'An Essay on Living with Severe ME'

    Trial By Error: 'An Essay on Living with Severe ME' First paragraph of a guest essay: "I started writing this, a few sentences a day, because I didn’t think it’d be long before I couldn’t type at all. I’ve had Severe ME for twenty-five years now: I can’t walk or get out of bed, I can’t sit up...
  14. forestglip

    Preprint Microvascular Remodeling and Endothelial Dysfunction Across Post-COVID-19 and ME/CFS: Insights from the All Eyes on PCS Study, 2026, Wallraven et al

    Microvascular Remodeling and Endothelial Dysfunction Across Post-COVID-19 and ME/CFS: Insights from the All Eyes on PCS Study [Line breaks added] Background Post-viral diseases, including post-COVID-19 syndrome (PCS) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), cause...
  15. forestglip

    The New Yorker: Did a Celebrated Researcher Obscure a Baby’s Poisoning?

    I got goosebumps there. Here's the article with the apparently made up case report: Baby boy blue – why is this newborn lethargic? Rieder, Michael; Koren, Gideon Web | DOI | PMC | PDF | Paediatrics & Child Health | Open access at PMC link --------- A thesis that cites the case report...
  16. forestglip

    The LIFT trial (OMF) - Pyridostigmine (mestinon) and Low Dose Naltrexone (LDN)

    Some posts about this trial have been moved to the thread for the trial: Trial registration: Low-dose Naltrexone for Post-COVID Fatigue Syndrome, 2022, Luis Nacul, British Columbia Women's Hospital & Health Centre
  17. forestglip

    Physical activity levels in ME/chronic fatigue syndrome before and after a 2-day cardiopulmonary exercise test protocol, 2026, Receno

    Maybe sedentary people are sedentary for a reason. Maybe more people than we thought have very mild ME/CFS or something like it.
  18. forestglip

    A cross-continental comparative analysis of the neurological manifestations of Long COVID, 2026, Jimenez et al

    A cross-continental comparative analysis of the neurological manifestations of Long COVID [Line breaks added] Objective To compare demographics, comorbidities, neurologic symptoms, quality of life, and cognitive outcomes among adult individuals with neurologic manifestations of post-acute...
Back
Top Bottom